BAP1 antibody (AA 460-729)

Catalog No. ABIN7174361

Product Details anti-BAP1 Antibody

Target: BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-terminal Hydrolase) (BAP1))

Binding Specificity: AA 460-729

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This BAP1 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Cross-Reactivity: Human

Purification: Antigen Affinity Purified

Immunogen: Recombinant Human Ubiquitin carboxyl-terminal hydrolase BAP1 protein (460-729AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: WB:1:200-1:1000,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for BAP1

Target: BAP1 (BRCA1 Associated Protein-1 (Ubiquitin Carboxy-terminal Hydrolase) (BAP1))

Alternative Name: BAP1 (BAP1 Products)

Synonyms: HUCEP-13 antibody, UCHL2 antibody, BAIAP3 antibody, 2300006C11Rik antibody, AA989761 antibody, AW553466 antibody, mKIAA0272 antibody, uch-x4 antibody, hucep-13 antibody, hucep-6 antibody, uchl2 antibody, si:dkey-42i9.9 antibody, BRCA1 associated protein 1 antibody, Brca1 associated protein 1 antibody, BRCA1 associated protein 1 L homeolog antibody, BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) antibody, BAP1 antibody, Bap1 antibody, bap1.L antibody, bap1 antibody

Background:

Background: Deubiquitinating enzyme that plays a key role in chromatin by mediating deubiquitination of histone H2A and HCFC1. Catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at \\\'Lys-119\\\' (H2AK119ub1). Does not deubiquitinate monoubiquitinated histone H2B. Acts as a regulator of cell growth by mediating deubiquitination of HCFC1 N-terminal and C-terminal chains, with some specificity toward \\\'Lys-48\\\'-linked polyubiquitin chains compared to \\\'Lys-63\\\'-linked polyubiquitin chains. Deubiquitination of HCFC1 does not lead to increase stability of HCFC1. Interferes with the BRCA1 and BARD1 heterodimer activity by inhibiting their ability to mediate ubiquitination and autoubiquitination. It however does not mediate deubiquitination of BRCA1 and BARD1. Able to mediate autodeubiquitination via intramolecular interactions to couteract monoubiquitination at the nuclear localization signal (NLS), thereby protecting it from cytoplasmic sequestration (PubMed:24703950). Acts as a tumor suppressor.

Aliases: BAP 1 antibody, Bap1 antibody, BAP1_HUMAN antibody, BRCA 1 associated protein 1 antibody, BRCA1 associated protein 1 antibody, BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) antibody, BRCA1-associated protein 1 antibody, Cerebral protein 13 antibody, Cerebral protein 6 antibody, DKFZp686N04275 antibody, FLJ35406 antibody, FLJ37180 antibody, HUCEP 13 antibody, Hucep 6 antibody, HUCEP13 antibody, Hucep6 antibody, KIAA0272 antibody, TPDS antibody, Ubiquitin carboxy terminal hydrolase antibody, Ubiquitin carboxyl terminal hydrolase BAP 1 antibody, Ubiquitin carboxyl terminal hydrolase BAP1 antibody, Ubiquitin carboxyl-terminal hydrolase BAP1 antibody, UCHL2 antibody

UniProt: Q92560